Rare diseases
Investigational molecules
Locations
Back to Austria61 clinical trials in Klagenfurt am Wörthersee, Austria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
AustriaStudy on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack
AustriaStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
AustriaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
AustriaStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
AustriaEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
AustriaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
AustriaTriple vs dual therapy with rosuvastatin, ezetimibe and bempedoic acid in patients with atherosclerotic heart disease and high cholesterol undergoing revascularisation
AustriaA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
AustriaSafety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
AustriaVMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk
AustriaHigh-Dose Colecalciferol for 28-Day Mortality in Critically Ill Adults with Severe Vitamin D Deficiency
AustriaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on hepatocellular carcinoma and non-small cell lung cancer, evaluating novel immunotherapy combinations and targeted treatments for improved patient outcomes.
Research includes innovative approaches combining immunotherapy with conventional treatments for various cancer types.
Clinical trials investigating treatments for atrial fibrillation, myocardial infarction, and cardiac conditions, focusing on preventing strokes and improving heart function.
Innovative approaches to treating and managing various cardiovascular conditions using both established and experimental medications.
Studies examining new treatments for multiple sclerosis and migraine headaches, with emphasis on improving patient quality of life and disease management.
Focus on developing targeted therapies for various neurological conditions affecting patients globally.
Research into interstitial lung diseases and community-acquired pneumonia, including COVID-19 related respiratory conditions.
Advanced therapeutic approaches for both acute and chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
